论文部分内容阅读
目的:探讨回肠膀胱术后回肠膀胱肿瘤的发病机制、临床病理、影像学特点和诊治方法。方法:对1例回肠膀胱肿瘤的临床资料进行回顾性分析,并结合文献复习。该例患者行尿常规、尿脱落细胞学、超声、CT、电子肠镜检查。肠镜取活检后病理(免疫组化)确定肿瘤类型。结果:病理报告示浸润的鳞状细胞癌,免疫组化染色结果示CK5/6(+),P63(+),CK7(+)。诊断为回肠膀胱鳞状细胞癌。结合患者全身状况,考虑行肿瘤放化疗,患者及其家属放弃进一步治疗。结论:回肠膀胱肿瘤临床罕见,大多数患者以血尿为首发症状,常伴有上尿路肿瘤的复发。诊断主要依靠尿常规、尿脱落细胞学、肠镜及其他影像学等检查,早期肿瘤治疗主要以手术为主,需根据肿瘤分级分期决定手术方案,晚期给予辅助放化疗。
Objective: To investigate the pathogenesis, clinical pathology, imaging characteristics and diagnosis and treatment of ileal bladder cancer after ileal bladder surgery. Methods: One case of ileal bladder tumor was retrospectively reviewed and reviewed. The patient underwent routine urine, urine cytology, ultrasound, CT, colonoscopy. Colonoscopy biopsy pathology (immunohistochemistry) to determine the type of tumor. Results: The pathological report showed infiltrating squamous cell carcinoma. The results of immunohistochemistry showed CK5 / 6 (+), P63 (+) and CK7 (+). Diagnosis of ileal bladder squamous cell carcinoma. Combined with the patient’s general condition, consider the line of tumor radiotherapy and chemotherapy, patients and their families to give up further treatment. Conclusion: The ileal bladder cancer is rare in clinic. Most patients have hematuria as the first symptom, often accompanied by recurrence of the upper urinary tract tumor. Diagnosis mainly rely on urine, urine cytology, colonoscopy and other imaging studies, early tumor treatment mainly surgery, according to the tumor grade staging decided surgical options, adjuvant radiotherapy and chemotherapy late.